Healthcare Biotech · Series B Stage Board Meeting

Healthcare Biotech Series B Board Deck Template

A complete board meeting presentation template for Healthcare Biotech startups at the Series B stage. KPI dashboard, financial performance, product update, sales pipeline, and strategic decisions — structured the way experienced boards run effective meetings.

All Templates

Meeting Cadence

Monthly formal board meeting + bi-weekly audit committee call

Meeting Length

3–4 hours

Pack Deadline

72 hours before meeting

Board Size

5–7 members: CEO, 2 investor directors, 2 independent directors, optional observer seats

Running Effective Series B Board Meetings

Series B board governance is increasingly institutional. Build a dedicated board operations function (can be the CFO or a fractional board secretary). Track all board commitments and action items in a formal tracker reviewed at the start of each meeting.

Healthcare Biotech Board Context

Healthcare boards require HIPAA-compliant board materials. Do not include individually identifiable patient data in board presentations. Use aggregated outcome metrics with de-identified examples.

Board Deck Structure — 8 Standard Sections

1. Agenda and Previous Action Item Review

Open with meeting agenda, approved minutes from the prior meeting, and status update on all prior action items. This sets accountability and context before any performance review.

2. KPI Dashboard — Healthcare Biotech Metrics

Present current period actuals vs. plan and vs. prior period for all key metrics. Traffic light status (green/yellow/red) on each metric makes the dashboard scannable.

  • Patient volume and revenue vs. plan by site
  • Payer mix breakdown and reimbursement rate trend
  • Prior authorization approval rate
  • Clinical outcome metrics vs. published benchmarks
  • Health system and payer contract pipeline

3. Financial Performance

  • Revenue by payer class and site of care
  • Gross margin after clinical labor and medical supplies
  • Accounts receivable days and collection rate
  • Cash and runway with expansion capital needs

4. Product and Engineering Update

  • FDA clearance or approval milestone progress
  • Clinical evidence publications and presentations
  • EHR integration completions and performance
  • Quality and safety event reporting summary

5. Sales, Marketing, and Pipeline Review

  • Health system partnership pipeline and close timeline
  • Payer coverage expansion status
  • Provider referral network growth by geography
  • ACO and value-based contract negotiations

6. Hiring and Team Update

Current headcount vs. plan, new hires this period, open roles, and any departures. Include a brief note on team health and any organizational design changes. Board visibility into executive team changes is a governance requirement.

7. Strategic Decisions and Discussion Topics

The most important section — this is why you have a board. Include 2–3 decisions or discussion topics that require board input or approval:

  • Reimbursement coverage expansion strategy
  • Geographic expansion site selection criteria
  • Payer negotiation strategy and rate increase requests
  • M&A targets in adjacent clinical specialties

8. Action Items and Next Meeting

Close the meeting by assigning all action items with owner, deadline, and success criteria. Confirm the next board meeting date. Distribute meeting minutes within 48 hours of the meeting.

Governance Requirements at the Series B Stage

Board Composition

5–7 members: CEO, 2 investor directors, 2 independent directors, optional observer seats. Audit and compensation committees are formally constituted.

Pack Distribution Timeline

72 hours before meeting. Board members should have enough time to review all materials and come prepared with questions — not learning the data for the first time during the meeting.

Formal Requirements

  • Formally approved board minutes
  • Audit committee quarterly financial review
  • Compensation committee equity and bonus approvals
  • Annual say-on-pay and director compensation review
  • Related-party transaction approval process
  • D&O and E&O insurance review annually

Frequently Asked Questions

What should a Series B Healthcare Biotech board deck include?

A Series B Healthcare Biotech board deck should cover: a KPI dashboard (Patient volume and revenue vs. plan by site, Payer mix breakdown and reimbursement rate trend, Prior authorization approval rate), financial performance, product update, sales pipeline, team update, and strategic decisions requiring board input. Healthcare boards require HIPAA-compliant board materials. Do not include individually identifiable patient data in board presentations. Use aggregated outcome metrics with de-identified examples.

How often should Series B startups have board meetings?

Monthly formal board meeting + bi-weekly audit committee call. Board meetings at the Series B stage are 3–4 hours and materials should be distributed 72 hours before meeting.

What Healthcare Biotech-specific metrics belong in the board deck KPI dashboard?

Your Healthcare Biotech board KPI dashboard should track: Patient volume and revenue vs. plan by site, Payer mix breakdown and reimbursement rate trend, Prior authorization approval rate, Clinical outcome metrics vs. published benchmarks, Health system and payer contract pipeline. Present current period actuals vs. plan and vs. prior period for each metric.

What should the financial section of a board deck include?

The financial section should cover: Revenue by payer class and site of care; Gross margin after clinical labor and medical supplies; Accounts receivable days and collection rate; Cash and runway with expansion capital needs. Send the financial data in the pre-read 48–72 hours before the meeting. The board meeting is for discussing implications and decisions, not for first-pass review.

What governance requirements apply to Series B startups?

Series B startups need: Formally approved board minutes, Audit committee quarterly financial review, Compensation committee equity and bonus approvals, Annual say-on-pay and director compensation review, Related-party transaction approval process, D&O and E&O insurance review annually. Board composition at this stage is typically 5–7 members: CEO, 2 investor directors, 2 independent directors, optional observer seats. Audit and compensation committees are formally constituted.. Series B board governance is increasingly institutional. Build a dedicated board operations function (can be the CFO or a fractional board secretary). Track all board commitments and action items in a formal tracker reviewed at the start of each meeting.

Download This Board Deck

Get the Healthcare Biotech Series B board deck as a Google Slides and PowerPoint template. Every slide pre-built with the right structure — customize with your metrics and ship your next board pack faster.

Includes board deck, action item tracker, and governance calendar template

Other Healthcare Biotech Stages